Participants 79 146 6
patients with acute coronary syndrome in the PROVE IT-TIMI 22 trial
Participants 443 505 7
large cohort of patients presenting across the spectrum of ACS
Participants 528 579 4
baseline (n = 3,761) and at four-months (n = 3,369)
Participants 583 657 4
patients randomized to atorvastatin 80 mg or pravastatin 40 mg after ACS i
Participants 1006 1042 3
patients with elevated baseline PlGF
